PUBLIC COMPANY
saveSuven Life Sciences Ltd
updated 21d ago
community read0 votes
pipeline
6
marketed
1
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(6)
pipeline depth6 products
2Phase 12Phase 21Phase 31Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy
- phase2Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
- phase2Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
- phase1Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants
- phase3Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
- phase2A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy
- phase2SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that